Platform Therapeutic Education in Heart Failure and Coronary Disease

NCT ID: NCT01869452

Last Updated: 2015-05-05

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

555 participants

Study Classification

INTERVENTIONAL

Study Start Date

2010-05-31

Study Completion Date

2014-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

A first therapeutic education is given before patient's discharge at the hospital, then a dedicated nurse follows patients through the phone,regularly according to patients' needs, continues to give advise on risk factors, information on medication and alert symptoms and therapeutic education.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Patients are assigned to an arm accordingly to their needs: class 1 with light therapeutic education, class 2 with moderate education, class 3 with heavy education. Assignement is based on the first education diagnosis during hospitalization time.

Quality of life and patient's knowledge are regularly evaluated through questionnaires

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Heart Failure Acute Coronary Syndrome Coronary Bypass Graft Stenosis of Native Artery Graft

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

SINGLE_GROUP

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

therapeutic education class 1

patients in class 1 will have a follow up call with therapeutic education every 3 months. this is the light follow up.

Group Type OTHER

therapeutic education

Intervention Type BEHAVIORAL

knowledge of disease, risk factors, diet, medication, alert symptoms

therapeutic education class 2

patients in class 2 will have a follow up call with therapeutic education every month. this is the moderate follow up

Group Type OTHER

therapeutic education

Intervention Type BEHAVIORAL

knowledge of disease, risk factors, diet, medication, alert symptoms

therapeutic education class 3

patients in class 3 will have a follow up call with therapeutic education twice a month. this is the heavy follow up.

Group Type OTHER

therapeutic education

Intervention Type BEHAVIORAL

knowledge of disease, risk factors, diet, medication, alert symptoms

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

therapeutic education

knowledge of disease, risk factors, diet, medication, alert symptoms

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* hospitalization for acute coronary syndrome (ST-segment elevation myocardial infarction ,no ST-segment elevation myocardial infarction ST , unstable angina)
* hospitalization for heart failure
* acute coronary syndrome \< 3 months
* heart failure \< 3 months
* coronary by-pass surgery \< 3 months

Exclusion Criteria

* complicated acute coronary syndrome (ventricular arrhythmia, heart failure, mechanical complications, cardiogenic shock)
* valvular cardiac pathology
* obstructive cardiomyopathy
* planned cardiac transplantation
* severe neurological or psychiatric troubles
* loss of autonomy
* other (refusal, language, nursing house, way of life not compatible with follow up, refusal of telephonic contacts)
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

union nationale de formation et d'evaluation en medecine cardio-vasculaire

UNKNOWN

Sponsor Role collaborator

Resicard

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Pr Ariel Cohen

head of the departement of cardiology,Saint Antoine hospital , Paris

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

ariel a cohen, md

Role: PRINCIPAL_INVESTIGATOR

Resicard

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Institut Coeur Effort Sante

Paris, , France

Site Status

Clinique Turin

Paris, , France

Site Status

Hopital Saint Antoine

Paris, , France

Site Status

Centre Cardiologique Alfred Kastler

Sarcelles, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Platform

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.